Brief: Theratechnologies Reports Data Showing High Expression Of Sortilin (Sort1) In Multiple Solid Tumors From Tissue Microarrays
Oct 26 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES REPORTS DATA SHOWING HIGH EXPRESSION OF
SORTILIN (SORT1) IN MULTIPLE SOLID TUMORS FROM TISSUE
MICROARRAYS
Source text for Eikon: ID:nGNX9vg3X2
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process